Since their first recognition in human cases about four decades ago, rotaviruses have
remained the leading cause of acute severe dehydrating diarrhea among infants and young …

Two new vaccines have recently been shown to be safe and effective in protecting young
children against severe rotavirus gastroenteritis. Although both vaccines are now marketed …

Background. The live oral rotavirus (RV) vaccines have shown a reduced efficacy in Africa.
Recent in vitro studies have shown binding of the RV surface protein (VP4) to histo–blood …

Exposure to human pathogenic viruses in recreational waters has been shown to cause
disease outbreaks. In the context of Article 14 of the revised European Bathing Waters …

OBJECTIVE: There is limited information available regarding the etiology of gastrointestinal
infections in Burkina Faso. The aim of this study was to investigate the prevalence and …

RotaTeq® is a pentavalent rotavirus vaccine that contains five human-bovine reassortant
strains (designated G1, G2, G3, G4, and P1) on the backbone of the naturally attenuated …

Diarrhoeal disease is a public health problem worldwide, mostly affecting children in
developing countries. In Nicaragua, diarrhoea is the second greatest cause of infant …

Rotavirus (RV) and norovirus (NoV) are considered the most common causes of viral
gastroenteritis in children. In this study, the prevalence of RV and NoV infection in 55 …

In Latin America and the Caribbean, rotavirus causes approximately 15,000 deaths, 75,000
hospitalizations, 2 million clinic visits and 10 million cases of rotavirus diarrhea annually …

Information about norovirus (NoV) infections in Central America is limited. Through a
passive community and hospital pediatric diarrhea surveillance program, a total of 542 stool …